Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 192329, 7 pages
http://dx.doi.org/10.1155/2015/192329
Research Article

Cyclic GMP-AMP Synthase Is Required for Cell Proliferation and Inflammatory Responses in Rheumatoid Arthritis Synoviocytes

1The Medical Laboratory Diagnostics Center, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, China
2Department of Bone and Joint Surgery, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, China

Received 3 September 2015; Revised 30 October 2015; Accepted 18 November 2015

Academic Editor: Magdalena Klink

Copyright © 2015 Yan Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Cohen, S. C. Radominski, J. J. Gomez-Reino et al., “Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis,” Arthritis & Rheumatology, vol. 66, no. 11, pp. 2924–2937, 2014. View at Publisher · View at Google Scholar
  2. S. K. Chang, Z. Gu, and M. B. Brenner, “Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11,” Immunological Reviews, vol. 233, no. 1, pp. 256–266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Bartok and G. S. Firestein, “Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis,” Immunological Reviews, vol. 233, no. 1, pp. 233–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Rodríguez-Carrio, P. López, and A. Suárez, “Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine,” Clinical Science, vol. 128, no. 8, pp. 449–464, 2015. View at Publisher · View at Google Scholar
  5. P. Conigliaro, C. Perricone, R. A. Benson et al., “The type I IFN system in rheumatoid arthritis,” Autoimmunity, vol. 43, no. 3, pp. 220–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Kim, S.-K. Cho, T.-U. Han et al., “A redundant epistatic interaction between IRF5 and STAT4 of the type i interferon pathway in susceptibility to lupus and rheumatoid arthritis,” Lupus, vol. 22, no. 13, pp. 1336–1340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. O. Watson, S. L. Bell, D. A. MacDuff et al., “The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy,” Cell Host & Microbe, vol. 17, no. 6, pp. 811–819, 2015. View at Publisher · View at Google Scholar
  8. X.-D. Li, J. Wu, D. Gao, H. Wang, L. Sun, and Z. J. Chen, “Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects,” Science, vol. 341, no. 6152, pp. 1390–1394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. E. E. Gray, P. M. Treuting, J. J. Woodward, and D. B. Stetson, “Cutting edge: cGAS is required for lethal autoimmune disease in the trex1-deficient mouse model of aicardi-goutières syndrome,” The Journal of Immunology, vol. 195, no. 5, pp. 1939–1943, 2015. View at Publisher · View at Google Scholar
  10. N. Jeremiah, B. Neven, M. Gentili et al., “Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations,” The Journal of Clinical Investigation, vol. 124, no. 12, pp. 5516–5520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Barkan, H. Kleinman, J. L. Simmons et al., “Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton,” Cancer Research, vol. 68, no. 15, pp. 6241–6250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Aletaha, T. Neogi, A. J. Silman et al., “2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative,” Arthritis and Rheumatism, vol. 62, no. 9, pp. 2569–2581, 2010. View at Google Scholar
  13. P. L. Meroni and G. Valesini, “Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective,” BioDrugs, vol. 28, supplement 1, pp. S5–S13, 2014. View at Publisher · View at Google Scholar
  14. H.-G. Zhang, Y. Wang, J. F. Xie et al., “Regulation of tumor necrosis factor α-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt,” Arthritis & Rheumatism, vol. 44, no. 7, pp. 1555–1567, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Chen, B. Casali, L. Pattacini, L. Boiardi, and C. Salvarani, “Tumor necrosis factor-α protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction,” Journal of Rheumatology, vol. 33, no. 6, pp. 1061–1068, 2006. View at Google Scholar · View at Scopus
  16. C.-R. Wang, A.-L. Shiau, S.-Y. Chen et al., “Amelioration of collagen-induced arthritis in rats by adenovirus-mediated PTEN gene transfer,” Arthritis and Rheumatism, vol. 58, no. 6, pp. 1650–1656, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Camps, T. Rückle, H. Ji et al., “Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis,” Nature Medicine, vol. 11, no. 9, pp. 936–943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Yamamoto, A. Fukuda, H. Seto et al., “Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts,” Arthritis & Rheumatism, vol. 48, no. 9, pp. 2682–2692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Peters, D. Wendholt, S. Strietholt et al., “The loss of α2β1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 64, no. 5, pp. 1359–1368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Dai, W. Wang, H. Cao et al., “Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway,” PLoS Pathogens, vol. 10, no. 4, Article ID e1003989, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. An, J. J. Woodward, T. Sasaki, M. Minie, and K. B. Elkon, “Cutting edge: antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction,” The Journal of Immunology, vol. 194, no. 9, pp. 4089–4093, 2015. View at Publisher · View at Google Scholar